UTSnakeyes 🐍
7K posts

UTSnakeyes 🐍
@UTSnakeyes
Mechanical Engr., Options Trader, Stock Trader, NFT, and Crypto fanatic. Never give up and trust in yourself.












No, Hims & Hers is not part of these 7 FDA warning letters. Those target sellers like Prime Sciences and Pink Pony Peptides pushing unapproved GLP-1 products (e.g., semaglutide analogs) labeled strictly "for research purposes only" or "not for human consumption"—but marketed for injection anyway. Hims sells compounded GLP-1s via telehealth prescriptions for patient use. They've gotten prior FDA letters (e.g., Sept 2025 for misleading claims) and faced 2026 scrutiny on mass-marketed compounded versions, but not this action. Always check FDA's site for latest.


$BTC currently red for the month of March. Making it 6 red months in a row if it closes here or lower on Tuesday. I don’t believe Bitcoin has ever gone 7 red months in a row… 🤔





CRAZY: 🇺🇸Coinbase rejects the latest CLARITY Act compromise, just as lawmakers said a deal was close.



🚨 POLITICS: COINBASE REJECTS LATEST SENATE STABLECOIN YIELD COMPROMISE @coinbase has told Senate offices it cannot support the newest CLARITY Act language on stablecoin yields, throwing another wrench into the crypto industry's top legislative priority. The exchange voiced concerns during a Monday meeting over the latest compromise text drafted by Senators Tillis and Alsobrooks, which bans passive stablecoin yield while allowing activity-based rewards. The new "economic equivalence" standard is broader than prior drafts. The resistance is reportedly less severe than CEO Brian Armstrong's January opposition that single-handedly derailed the bill's markup. Talks are continuing, but without Coinbase's backing the legislation faces a difficult path. Senator Moreno has warned the bill stalls indefinitely if it doesn't pass by May.






